Multiparametric magnetic resonance imaging in the management and diagnosis of prostate cancer: current applications and strategies (Q38178850)

30 August 2017

title

Multiparametric magnetic resonance imaging in the management and diagnosis of prostate cancer: current applications and strategies (English)

1 reference

30 August 2017

1 reference

3

Caroline M Moore

1 reference

30 August 2017

4

Mark Emberton

1 reference

30 August 2017

Daniel J Lee

1

1 reference

30 August 2017

Hashim U Ahmed

series ordinal

2

1 reference

30 August 2017

Behfar Ehdaie

series ordinal

5

1 reference

30 August 2017

publication date

1 March 2014

1 reference

30 August 2017

published in

Current urology reports

1 reference

30 August 2017

volume

15

1 reference

30 August 2017

issue

3

1 reference

30 August 2017

page(s)

390

1 reference

https://scigraph.springernature.com/pub.10.1007/s11934-013-0390-1

30 August 2017

exact match

0 references

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

Critical review of prostate cancer predictive tools

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

Outcomes of localized prostate cancer following conservative management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

Long-term functional outcomes after treatment for localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

Prostate-cancer mortality at 11 years of follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

Pathological outcomes of candidates for active surveillance of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

High diagnostic ability of multiparametric magnetic resonance imaging to detect anterior prostate cancer missed by transrectal 12-core biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

The male lumpectomy: rationale for a cancer targeted approach for prostate cryoablation. A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

Treatment of localized prostate cancer using high-intensity focused ultrasound.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

Does photodynamic therapy have the necessary attributes to become a future treatment for organ-confined prostate cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging--clinicopathologic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

Carcinoma of the prostate gland: MR imaging with pelvic phased-array coils versus integrated endorectal--pelvic phased-array coils

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer. Results of a multi-institutional cooperative trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

MR imaging and sonography of early prostatic cancer: pathologic and imaging features that influence identification and diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

Anterior-predominant prostatic tumors: zone of origin and pathologic outcomes at radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

'Prostatic evasive anterior tumours': the role of magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

Correlation of Gleason scores with diffusion-weighted imaging findings of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

Histologic grading of prostate cancer: a perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

Diffusion-weighted magnetic resonance imaging: a potential non-invasive marker of tumour aggressiveness in localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

Apparent diffusion coefficient values in peripheral and transition zones of the prostate: comparison between normal and malignant prostatic tissues and correlation with histologic grade.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

Prostate MRI: who, when, and how? Report from a UK consensus meeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

The role of conventional and functional endorectal magnetic resonance imaging in the decision of whether to preserve or resect the neurovascular bundles during radical retropubic prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

Locally recurrent prostate cancer after external beam radiation therapy: diagnostic performance of 1.5-T endorectal MR imaging and MR spectroscopic imaging for detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

Predicting the probability of deferred radical treatment for localised prostate cancer managed by active surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

Expectant management of prostate cancer with curative intent: an update of the Johns Hopkins experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

Magnetic resonance imaging for predicting prostate biopsy findings in patients considered for active surveillance of clinically low risk prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

Utility of saturation biopsy to predict insignificant cancer at radical prostatectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

Prediction of organ-confined prostate cancer: incremental value of MR imaging and MR spectroscopic imaging to staging nomograms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

Prediction of seminal vesicle invasion in prostate cancer: incremental value of adding endorectal MR imaging to the Kattan nomogram

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

Prostate cancer: multiparametric MR imaging for detection, localization, and staging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

Preoperative nomograms incorporating magnetic resonance imaging and spectroscopy for prediction of insignificant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

Accuracy of multiparametric magnetic resonance imaging in confirming eligibility for active surveillance for men with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

Diffusion-weighted magnetic resonance imaging for monitoring prostate cancer progression in patients managed by active surveillance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

Prospective evaluation of 3-T MRI performed before initial transrectal ultrasound-guided prostate biopsy in patients with high prostate-specific antigen and no previous biopsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

Detection and localization of prostate cancer with the targeted biopsy strategy based on ADC map: a prospective large-scale cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

Standards of Reporting for MRI-targeted Biopsy Studies (START) of the Prostate: Recommendations from an International Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

Prospective Assessment of Prostate Cancer Aggressiveness Using 3-T Diffusion-Weighted Magnetic Resonance Imaging–Guided Biopsies Versus a Systematic 10-Core Transrectal Ultrasound Prostate Biopsy Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

Multiparametric MR imaging for detection of clinically significant prostate cancer: a validation cohort study with transperineal template prostate mapping as the reference standard

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

Value of magnetic resonance spectroscopy imaging and dynamic contrast-enhanced imaging for detecting prostate cancer foci in men with prior negative biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

Prostatic biopsy directed with endorectal MR spectroscopic imaging findings in patients with elevated prostate specific antigen levels and prior negative biopsy findings: early experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

Prostate cancer gene 3 and multiparametric magnetic resonance can reduce unnecessary biopsies: decision curve analysis to evaluate predictive models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

Organ-confined prostate cancer: effect of prior transrectal biopsy on endorectal MRI and MR spectroscopic imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

Prostate cancer: relationships between postbiopsy hemorrhage and tumor detectability at MR diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

Prostate cancer: effect of postbiopsy hemorrhage on interpretation of MR images.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

Endorectal magnetic resonance imaging at 1.5 Tesla to assess local recurrence following radical prostatectomy using T2-weighted and contrast-enhanced imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

Role of MRI in follow-up after focal therapy for prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

Preoperative prediction of multifocal prostate cancer and application of focal therapy: review 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

Referenceless MR thermometry for monitoring thermal ablation in the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

Comparison of combined x-ray radiography and magnetic resonance (XMR) imaging-versus computed tomography-based dosimetry for the evaluation of permanent prostate brachytherapy implants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

The use of magnetic resonance imaging for image-guided brachytherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

Magnetic resonance-guided high-intensity ultrasound ablation of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

Laser-induced thermal therapy for tumor ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

Role of MRI in minimally invasive focal ablative therapy for prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

Endorectal magnetic resonance imaging and magnetic resonance spectroscopy to monitor the prostate for residual disease or local cancer recurrence after transrectal high-intensity focused ultrasound

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

[MR detection of local prostate cancer recurrence after transrectal high-intensity focused US treatment: preliminary results]

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

Prostatic cancer surveillance following whole-gland high-intensity focused ultrasound: comparison of MRI and prostate-specific antigen for detection of residual or recurrent disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

TOOKAD(®) Soluble vascular-targeted photodynamic (VTP) therapy: determination of optimal treatment conditions and assessment of effects in patients with localised prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

ESUR prostate MR guidelines 2012

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

The utility of magnetic resonance imaging and spectroscopy for predicting insignificant prostate cancer: an initial analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

Assessment of aggressiveness of prostate cancer: correlation of apparent diffusion coefficient with histologic grade after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

21 January 2018

What is a real nomogram?

1 reference

https://api.crossref.org/works/10.1007%2FS11934-013-0390-1

Dynamic TurboFLASH subtraction technique for contrast-enhanced MR imaging of the prostate: correlation with histopathologic results

21 January 2018

1 reference

12 December 2020

Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer

1 reference

12 December 2020

The value of dynamic contrast-enhanced MRI in the detection of recurrent prostate cancer after external beam radiotherapy: correlation with transrectal ultrasound and pathological findings.

1 reference

12 December 2020

Prostatic cryosurgery: use of MR imaging in evaluation of success and technical modifications

1 reference

12 December 2020

Nonpalpable prostate cancer: detection with MR imaging

1 reference

12 December 2020

Consensus statements on radiation therapy of prostate cancer: guidelines for prostate re-biopsy after radiation and for radiation therapy with rising prostate-specific antigen levels after radical prostatectomy. American Society for Therapeutic Radi

1 reference

12 December 2020

EAU guidelines on prostate cancer

1 reference

12 December 2020

An analysis of 148 consecutive transition zone cancers: clinical and histological characteristics

1 reference

12 December 2020

Clinical relevance of trans-rectal ultrasound, biopsy, and serum prostate-specific antigen following external beam radiotherapy for carcinoma of the prostate.

1 reference

12 December 2020

Prostate MR imaging at 3T using a phased-arrayed coil in predicting locally recurrent prostate cancer after radiation therapy: preliminary experience

1 reference

12 December 2020

Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging-targeted and systematic biopsy for significant prostate cancer detection

1 reference

12 December 2020

Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen

1 reference

12 December 2020

Multiparametric magnetic resonance imaging of the prostate can improve the predictive value of the urinary prostate cancer antigen 3 test in patients with elevated prostate-specific antigen levels and a previous negative biopsy

1 reference

12 December 2020

Dynamic contrast-enhanced MRI of anterior prostate cancer: morphometric assessment and correlation with radical prostatectomy findings

1 reference

12 December 2020

Prospective evaluation of men with stage T1C adenocarcinoma of the prostate

1 reference

12 December 2020

Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores

1 reference

12 December 2020

Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Localization of Recurrent Prostate Cancer After External Beam Radiotherapy

1 reference

12 December 2020

Accuracy of multiparametric magnetic resonance imaging in detecting recurrent prostate cancer after radiotherapy

1 reference

12 December 2020

Active surveillance for prostate cancers detected in three subsequent rounds of a screening trial: characteristics, PSA doubling times, and outcome

1 reference

12 December 2020

Endorectal and dynamic contrast-enhanced MRI for detection of local recurrence after radical prostatectomy

1 reference

12 December 2020

MAGNETIC RESONANCE IMAGING OF CLINICALLY LOCALIZED PROSTATIC CANCER

1 reference

12 December 2020

Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread

1 reference

12 December 2020

Initial experience with identifying high-grade prostate cancer using diffusion-weighted MR imaging (DWI) in patients with a Gleason score ≤ 3 + 3 = 6 upon schematic TRUS-guided biopsy: a radical prostatectomy correlated series

1 reference

12 December 2020

Infective complications after prostate biopsy: outcome of the Global Prevalence Study of Infections in Urology (GPIU) 2010 and 2011, a prospective multinational multicentre prostate biopsy study.

1 reference

12 December 2020

Suspected local recurrence after radical prostatectomy: endorectal coil MR imaging

1 reference

12 December 2020

MR imaging of prostate cancer with an endorectal surface coil technique: correlation with whole-mount specimens

1 reference

12 December 2020

Tumorsize dependent detection rate of endorectal MRI of prostate cancer--a histopathologic correlation with whole-mount sections in 70 patients with prostate cancer

1 reference

12 December 2020

Defining prostate specific antigen progression after radical prostatectomy: what is the most appropriate cut point?

1 reference

12 December 2020

Counseling Men With Prostate Cancer: A Nomogram for Predicting the Presence of Small, Moderately Differentiated, Confined Tumors

1 reference

12 December 2020

The impact of repeat biopsies on infectious complications in men with prostate cancer on active surveillance

1 reference

12 December 2020

Combined T2-Weighted and Diffusion-Weighted MRI for Localization of Prostate Cancer

1 reference

12 December 2020

MAPPED study design: a 6 month randomised controlled study to evaluate the effect of dutasteride on prostate cancer volume using magnetic resonance imaging

1 reference

12 December 2020

PSA doubling time predicts the outcome after active surveillance in screening-detected prostate cancer: Results from the European randomized study of screening for prostate cancer, Sweden section

1 reference

12 December 2020

Comparing the Gleason prostate biopsy and Gleason prostatectomy grading system: the Lahey Clinic Medical Center experience and an international meta-analysis

1 reference

12 December 2020

10.1007/S11934-013-0390-1

Identifiers

DOI

1 reference

Dimensions Publication ID

30 August 2017

1019553044

0 references

1 reference